FDA Drug recall D-0899-2017
NasalCrom (cromolyn sodium) Nasal Spray, USP, 5.2 mg per spray, 200 metered sprays, 0.88 FL OZ (26 mL) metered spray pump bottle, Distribut…
- FDA Drug
- Class II
- terminated
- Published 2017-06-21
On 2017-06-21 the FDA classified a Class II recall of NasalCrom (cromolyn sodium) Nasal Spray, USP, 5.2 mg per spray, 200 metered sprays, 0.88 FL OZ (26 mL) metered spray pump bottle, Distribut… by Bausch And Lomb, citing CGMP Deviations: Possibility of the presence of microbial contamination in the water used to manufacture this product lot.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0899-2017 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2017-06-06 |
| Published | 2017-06-21 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Bausch And Lomb |
| Distribution | US |
Product
NasalCrom (cromolyn sodium) Nasal Spray, USP, 5.2 mg per spray, 200 metered sprays, 0.88 FL OZ (26 mL) metered spray pump bottle, Distributed by: Medtech Products, Inc., Tarrytown, NY 10591, UPC 8 148332 01101 7.
Reason
CGMP Deviations: Possibility of the presence of microbial contamination in the water used to manufacture this product lot.
Identifiers
| upc | 8148332011017 |
|---|---|
| code_info | Lot: 253211, Exp 12/18 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0899-2017%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.